The Ensign Group, Inc. (ENSG)
USD 136.41
(-2.56%)
USD 136.41
(-2.56%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.36 Billion USD | 8.26% |
| 2022 | 1.25 Billion USD | 25.39% |
| 2021 | 1 Billion USD | 14.32% |
| 2020 | 877.44 Million USD | -31.86% |
| 2019 | 1.28 Billion USD | 506.95% |
| 2018 | 212.15 Million USD | -21.6% |
| 2017 | 270.59 Million USD | 19.78% |
| 2016 | 225.9 Million USD | 288.81% |
| 2015 | 58.1 Million USD | 223.11% |
| 2014 | 17.98 Million USD | -90.71% |
| 2013 | 193.55 Million USD | 16.06% |
| 2012 | 166.76 Million USD | 5.36% |
| 2011 | 158.28 Million USD | 124.78% |
| 2010 | 70.41 Million USD | -0.27% |
| 2009 | 70.61 Million USD | 267.29% |
| 2008 | 19.22 Million USD | 62.4% |
| 2007 | 11.83 Million USD | -69.67% |
| 2006 | 39.03 Million USD | 170.73% |
| 2005 | 14.41 Million USD | 0.0% |
| 2003 | 15.49 Million USD | 47.93% |
| 2002 | 10.47 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.42 Billion USD | 4.59% |
| 2024 Q3 | -385.43 Million USD | 0.43% |
| 2024 Q2 | 1.47 Billion USD | 3.89% |
| 2023 Q4 | 1.36 Billion USD | -4.2% |
| 2023 FY | 1.36 Billion USD | 8.26% |
| 2023 Q1 | 1.57 Billion USD | 25.59% |
| 2023 Q2 | 1.46 Billion USD | -7.08% |
| 2023 Q3 | 1.42 Billion USD | -3.16% |
| 2022 Q1 | 1.17 Billion USD | 16.85% |
| 2022 Q3 | 1.16 Billion USD | 1.86% |
| 2022 FY | 1.25 Billion USD | 25.39% |
| 2022 Q2 | 1.14 Billion USD | -2.36% |
| 2022 Q4 | 1.25 Billion USD | 7.88% |
| 2021 Q1 | 982.89 Million USD | 12.02% |
| 2021 FY | 1 Billion USD | 14.32% |
| 2021 Q2 | 1 Billion USD | 1.97% |
| 2021 Q3 | 984.83 Million USD | -1.73% |
| 2021 Q4 | 1 Billion USD | 1.86% |
| 2020 Q1 | 1.3 Billion USD | 0.99% |
| 2020 Q4 | 877.44 Million USD | -6.77% |
| 2020 Q2 | 950.67 Million USD | -26.9% |
| 2020 Q3 | 941.18 Million USD | -1.0% |
| 2020 FY | 877.44 Million USD | -31.86% |
| 2019 Q2 | 1.28 Billion USD | 4.27% |
| 2019 Q3 | 1.26 Billion USD | -1.58% |
| 2019 Q4 | 1.28 Billion USD | 1.65% |
| 2019 FY | 1.28 Billion USD | 506.95% |
| 2019 Q1 | 1.23 Billion USD | 481.81% |
| 2018 Q3 | 210.02 Million USD | -16.3% |
| 2018 Q4 | 212.15 Million USD | 1.01% |
| 2018 Q2 | 250.94 Million USD | -1.76% |
| 2018 FY | 212.15 Million USD | -21.6% |
| 2018 Q1 | 255.42 Million USD | -5.6% |
| 2017 Q1 | 235.12 Million USD | 4.08% |
| 2017 Q4 | 270.59 Million USD | 5.88% |
| 2017 Q3 | 255.57 Million USD | -1.38% |
| 2017 Q2 | 259.15 Million USD | 10.22% |
| 2017 FY | 270.59 Million USD | 19.78% |
| 2016 Q3 | 130.2 Million USD | -13.68% |
| 2016 FY | 225.9 Million USD | 288.81% |
| 2016 Q4 | 225.9 Million USD | 73.51% |
| 2016 Q2 | 150.83 Million USD | 58.94% |
| 2016 Q1 | 94.89 Million USD | 63.33% |
| 2015 Q4 | 58.1 Million USD | 95.28% |
| 2015 Q3 | 29.75 Million USD | 2768.43% |
| 2015 Q2 | -1.11 Million USD | 98.12% |
| 2015 Q1 | -59.24 Million USD | -429.47% |
| 2015 FY | 58.1 Million USD | 223.11% |
| 2014 FY | 17.98 Million USD | -90.71% |
| 2014 Q2 | -22.39 Million USD | -111.2% |
| 2014 Q3 | -35.78 Million USD | -59.82% |
| 2014 Q4 | 17.98 Million USD | 150.24% |
| 2014 Q1 | 200.01 Million USD | 3.34% |
| 2013 Q1 | 163.39 Million USD | -2.02% |
| 2013 Q4 | 193.55 Million USD | 16.31% |
| 2013 Q2 | 186.67 Million USD | 14.25% |
| 2013 Q3 | 166.4 Million USD | -10.86% |
| 2013 FY | 193.55 Million USD | 16.06% |
| 2012 Q3 | 167.4 Million USD | -0.57% |
| 2012 Q1 | 170.23 Million USD | 7.55% |
| 2012 Q2 | 168.36 Million USD | -1.1% |
| 2012 Q4 | 166.76 Million USD | -0.38% |
| 2012 FY | 166.76 Million USD | 5.36% |
| 2011 Q1 | 90.84 Million USD | 29.01% |
| 2011 FY | 158.28 Million USD | 124.78% |
| 2011 Q4 | 158.28 Million USD | 6.41% |
| 2011 Q3 | 148.75 Million USD | 45.78% |
| 2011 Q2 | 102.03 Million USD | 12.32% |
| 2010 Q2 | 82.13 Million USD | 21.68% |
| 2010 Q4 | 70.41 Million USD | -0.94% |
| 2010 Q3 | 71.08 Million USD | -13.45% |
| 2010 FY | 70.41 Million USD | -0.27% |
| 2010 Q1 | 67.5 Million USD | -4.4% |
| 2009 Q4 | 70.61 Million USD | 83.94% |
| 2009 Q3 | 38.38 Million USD | 45.8% |
| 2009 Q2 | 26.33 Million USD | -3.26% |
| 2009 FY | 70.61 Million USD | 267.29% |
| 2009 Q1 | 27.21 Million USD | 41.57% |
| 2008 Q2 | 10.12 Million USD | 14.22% |
| 2008 FY | 19.22 Million USD | 62.4% |
| 2008 Q4 | 19.22 Million USD | 335.25% |
| 2008 Q3 | 4.41 Million USD | -56.36% |
| 2008 Q1 | 8.86 Million USD | -25.15% |
| 2007 Q1 | 47.86 Million USD | 22.6% |
| 2007 Q3 | 57.41 Million USD | 12.43% |
| 2007 FY | 11.83 Million USD | -69.67% |
| 2007 Q4 | 11.83 Million USD | -79.38% |
| 2007 Q2 | 51.06 Million USD | 6.69% |
| 2006 FY | 39.03 Million USD | 170.73% |
| 2006 Q4 | 39.03 Million USD | 0.0% |
| 2005 Q4 | 14.41 Million USD | 0.0% |
| 2005 FY | 14.41 Million USD | 0.0% |
| 2003 FY | 15.49 Million USD | 47.93% |
| 2002 FY | 10.47 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 3.472% |
| Addus HomeCare Corporation | 110.39 Million USD | -1133.5% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | -1423.022% |
| Amedisys, Inc. | 341.35 Million USD | -298.908% |
| American Oncology Network, Inc. | 99.78 Million USD | -1264.593% |
| Astrana Health, Inc. | 27.2 Million USD | -4904.863% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 6.43% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 614820.262% |
| biote Corp. | 25.86 Million USD | -5163.725% |
| Cryo-Cell International, Inc. | 10.48 Million USD | -12880.723% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 11613.258% |
| COMPASS Pathways plc | -187.58 Million USD | 825.885% |
| DocGo Inc. | -12.78 Million USD | 10747.217% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 12831.865% |
| InnovAge Holding Corp. | 56.08 Million USD | -2327.701% |
| Assure Holdings Corp. | 14.68 Million USD | -9174.438% |
| The Joint Corp. | -2.47 Million USD | 55018.127% |
| LifeStance Health Group, Inc. | 432.21 Million USD | -215.043% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 22604.901% |
| ModivCare Inc. | 1.13 Billion USD | -19.73% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -488920.611% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | -33477.399% |
| Option Care Health, Inc. | 822.56 Million USD | -65.54% |
| P3 Health Partners Inc. | 83.7 Million USD | -1526.713% |
| P3 Health Partners Inc. | 83.7 Million USD | -1526.713% |
| The Pennant Group, Inc. | 323.57 Million USD | -320.824% |
| Surgery Partners, Inc. | 2.86 Billion USD | 52.484% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 45010.474% |
| Talkspace, Inc. | -123.9 Million USD | 1198.939% |
| Talkspace, Inc. | -123.9 Million USD | 1198.939% |
| The Oncology Institute, Inc. | 86.32 Million USD | -1477.343% |
| The Oncology Institute, Inc. | 86.32 Million USD | -1477.343% |